All Blogs

The global migraine market is expected to reach US$5.10 billion in 2024, growing at a CAGR of 3.7%, for the duration spanning 2020-2024. The factors such as growing female population, increasing cigarette consumption, increasing pharmaceutical R&D expenditures, accelerating economic growth, increasing healthcare spending, increasing stress levels, unmet medical needs and prevalence of migra ..

The global gene therapy market is expected to reach US$6.42 billion in 2024, witnessing growth at a CAGR of 19.29%, over the period 2020-2024. Growth in the gene therapy market has accrued due to the increasing prevalence of chronic diseases, rising healthcare expenditure, expanding urbanization, growth of gene therapy clinical trials and upsurge in economic growth. The market is anticipat ..

The US acne market is expected to reach US$4.49 billion in 2024, recording growth at a CAGR of 4.12% during the period spanning 2019-2024. The US rosacea market is expected to reach US$1.80 billion in 2024, growing at a CAGR of 5.92% during the period spanning 2019-2024. Growth in the acne and rosacea market has accrued due to the rising youth population, increasing purchasing power of the cons ..

The global endoscopy market is predicted to reach US$41.15 billion in 2024, witnessing growth at a CAGR of 6.75%, over the period 2020-2024. The factors such as rising healthcare expenditure, growing occurrence of chronic diseases, rising obese population, increasing elderly population and economic growth are expected to drive the market. A few notable trends include the upsurge in alcohol cons ..

The global dialysis market is estimated to reach US$127.4 billion in 2024, growing at a CAGR of 6.29% for the period spanning from 2020 to 2024. The factors such as higher prevalence among aging population, increasing diabetic population, rising healthcare spending and increasing cases of ESRD are expected to drive the market. However, growth of the industry will be challenged by high treatment ..

The global monoclonal antibodies market is expected to reach US$161.7 billion in 2024, increasing at a CAGR of 7.21%, for the duration of 2020-2024. The factors such as, increasing incidences of new cancer cases, escalating sales of biologics, growth in geriatric population, increasing pharmaceutical R&D spending, rise in prevalence of diabetes and upsurge in healthcare expenditure would dr ..

The global robotic surgery market is forecasted to reach US$6.84 billion in 2024, growing at a CAGR of 14.79% for the period spanning 2020-2024. The factors such as rising cancer patients, increasing geriatric population, growing personal healthcare expenditures, shortage of surgeons, improving consumer confidence, accelerating personal disposable income, favorable reimbursement policies and ri ..

The global non-alcoholic steatohepatitis (NASH) drugs market is expected to reach US$84.34 billion in 2029, growing at a CAGR of 39.13%, for the duration spanning 2018-2029. The factors such as rising healthcare expenditure, increasing pharmaceutical R&D expenditure, surging diabetic population, escalating obese population, unmet medical needs and sedentary lifestyles are expected to drive ..

The global multiplex assays market is expected to reach US$4.87 billion in 2024, increasing at a CAGR of 7.18%, for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV, rising incidences of cancer cases, increasing medical technology R&D spending, growth in geriatric population, upsurge in healthcare expenditures, rise of multiplex immunoassays in drug discover ..

The global telehealth market is forecasted to reach US$20.18 billion in 2024, growing at a CAGR of 7.95% for the period spanning 2020-2024. The factors such as rising chronic respiratory disease incidence, increasing geriatric population, inclining personal healthcare expenditures, growing possession of smartphones, escalating online consultants in China and supportive government policies& ..